Clinical Data
In a pilot clinical study (N=2, ST V), ClearLift Pro laser showed improvement in hyperpigmentation after 6 treatments, with results maintained at the 3-month follow-up. Treatments caused minimal pain, with a combined average pain score of 2.5 out of 10 across 12 treatments. Notably no acute or delayed adverse events, PIH, or hypopigmentation were observed in phototype V skin type2.
Features & Benefits
- Multiple handpieces in one device
- Treat over 130 indications across all skin types
- Potential for incredible growth and ROI
- No consumables
Clinical Resources
-
Treatment of posttraumatic scar with ablative fractional [Er:YAG] laser
-
Intraepidermal erbium:YAG laser resurfacing: Impact on the dermal matrix
-
Depth of tissue ablation and residual thermal damage caused by a 2,940 nm laser in a swine
-
Results of fractional ablative facial skin resurfacing [Er:YAG] laser 1 week and 2 months
¹ https://www.imarcgroup.com/anti-aging-market
² https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586531/
³ Data on file